- Partnership underscores Medtronic's commitment to investing in innovative technologies that support physicians and patients from diagnosis to treatment
- CathWorks' FFRangio® System provides diagnostic and physiologic information through artificial intelligence to potentially disrupt traditional FFR and revolutionize the management of coronary artery disease
As part of the agreement, Medtronic will invest up to
Fractional flow reserve (FFR) is a diagnostic technique that evaluates the physiologic impact of coronary artery stenosis, making it an important part of the decision-making process when managing patients with CAD. While FFR is an important diagnostic tool, supported by strong clinical evidence,1 the nature of traditional FFR — which requires invasive measurements with wires and stimulation with hyperemic agents— has resulted in its underutilization. In contrast to traditional FFR, the FFRangio System combines artificial intelligence (AI) and advanced computational science to obtain quick and reliable FFR values from routine angiograms (X-rays), eliminating the need for drug stimulation and invasive pressure wires.
"Data and AI-enabled technologies have been shown to drive improved workflow and patient outcomes across the healthcare ecosystem. In cardiology specifically, these new advances in technology provide clinicians with the opportunity to gain additional information to improve and evolve the diagnosis and treatment of patients with CAD," said
Backed by robust clinical evidence, FFRangio has demonstrated excellent diagnostic performance compared to wire-based FFR. According to clinical data published in the
"CathWorks has been looking for the right partner to help us expand the reach of the FFRangio system globally," said
Financial Highlights
The co-promotion agreement is expected to be neutral to Medtronic's fiscal year 2023 GAAP and adjusted earnings per share and neutral to accretive thereafter.
About CathWorks
CathWorks is the leader in digital health innovations that can improve the lives of patients globally. The CathWorks FFRangio® System combines artificial intelligence and advanced computational science, transforming how cardiovascular disease is diagnosed and treated. The FFRangio System obtains physiologic information from routine angiograms, eliminating the need for drug stimulation and invasive pressure wires. It provides physicians with quick and reliable intraprocedural FFR values for the entire coronary tree that is practical for every patient. For more information on CathWorks, visit www.cath.works and follow @CathWorks on Twitter and LinkedIn.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the
Bernard De Bruyne , M.D., Ph.D., Nico H.J. Pijls, M.D., Ph.D.,Bindu Kalesan , M.P.H.,Emanuele Barbato , M.D., Ph.D.,Pim A.L. Tonino , M.D., Ph.D.,Zsolt Piroth , M.D.,Nikola Jagic , M.D., Sven Möbius-Winkler , M.D., Gilles Rioufol, M.D., Ph.D.,Nils Witt , M.D., Ph.D.,Petr Kala , M.D.,Philip MacCarthy , M.D., Thomas Engström, M.D.,Keith G. Oldroyd , M.D., Kreton Mavromatis, M.D.,Ganesh Manoharan , M.D.,Peter Verlee , M.D., Ole Frobert, M.D., Nick Curzen, B.M., Ph.D.,Jane B. Johnson , R.N., B.S.N., Peter Jüni, M.D., andWilliam F. Fearon , M.D., for the FAME 2 Trial Investigators. Fractional Flow Reserve–Guided PCI versus Medical Therapy in stable coronary disease.The New England Journal of Medicine 2012; 367:991-1001DOI: 10.1056/NEJMoa1205361- Witberg G, De Bruyne B, Fearon WF, Achenbach S, Engstrom T, Matsuo H, et al. . Diagnostic performance of angiogram-derived fractional flow reserve: a pooled analysis of 5 prospective cohort studies. JACC Cardiovasc Interv. (2020) 13:488–97. 10.1016/j.jcin.2019.10.045
Contacts: | |
Lauren Mueller Doran | |
Public Relations | Investor Relations |
+1-763-285-9053 | +1-763-505-4626 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-announces-co-promotion-agreement-with-cathworks-with-path-toward-acquisition-301584427.html
SOURCE
© Canada Newswire, source